Letter: optimising response to ustekinumab therapy for patients with Crohn's disease. Hudson J, Herfarth HH, Barnes EL. Aliment Pharmacol Ther 2020;52:906.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hudson J, Herfarth HH, Barnes EL. Letter: optimising response to ustekinumab therapy for patients with Crohn's disease. Aliment Pharmacol Ther 2020;52:906.
PMID: 32852815